EUVIMEDEUVIMED entdecken
Crossref

Substituting Poly(ethylene glycol) Lipids with Poly(2‐ethyl‐2‐oxazoline) Lipids Improves Lipid Nanoparticle Repeat Dosing

Alejandro J Da Silva Sanchez, David Loughrey, Elisa Schrader Echeverri, Sebastian G Huayamares, Afsane Radmand, Kalina Paunovska, Marine Hatit, Karen E Tiegreen, Philip J Santangelo, James E Dahlman iD

Advanced Healthcare Materials · 2024-07 · 13 (17)

DOI: 10.1002/adhm.202304033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 10.03.2024. Verfasst von Alejandro J Da Silva Sanchez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA, 30332, USA. Hauptthemen laut MEDLINE: Polyethylene Glycols, Polyamines, Nanoparticles, Lipids. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poly(ethylene glycol) (PEG)–lipids are used in Food‐and‐Drug‐Administration‐approved lipid nanoparticle (LNP)–RNA drugs, which are safe and effective. However, it is reported that PEG–lipids may also contribute to accelerated blood clearance and rare cases of hypersensitivity; this highlights the utility of exploring PEG–lipid alternatives. Here, it is shown that LNPs containing poly(2‐ethyl‐2‐oxazoline) (PEOZ)–lipids can deliver messenger RNA (mRNA) to multiple cell types in mice inside and outside the liver. In addition, it is reported that LNPs formulated with PEOZ–lipids show reduced clearance from the bloodstream and lower levels of antistealth lipid immunoglobulin Ms than LNPs formulated with PEG–lipids. These data justify further exploration of PEOZ–lipids as alternatives to PEG–lipids in LNP–RNA formulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polyethylene GlycolsPolyaminesNanoparticlesLipidsAnimalsMiceHumansRNA, Messenger

Stichwörter der Autor:innen

LNPPEGlipid nanoparticlesmRNApoly(2‐ethyl‐2‐oxazoline)polyethylene glycol

Substanzen

Polyethylene GlycolsPolyaminespoly(2-ethyl-2-oxazoline)LipidsRNA, Messenger

Autor:innen und Institutionen

  • Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA, 30332, USA.
  • Department of Chemical Engineering, Georgia Institute of Technology, Atlanta, GA, 30332, USA.
  • Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, 30332, USA.

ORCID-Profile: James E Dahlman

Zitieren

APA

Sanchez, A. J. D. S., Loughrey, D., Echeverri, E. S., Huayamares, S. G., Radmand, A., Paunovska, K., Hatit, M., Tiegreen, K. E., Santangelo, P. J., & Dahlman, J. E. (2024). Substituting Poly(ethylene glycol) Lipids with Poly(2‐ethyl‐2‐oxazoline) Lipids Improves Lipid Nanoparticle Repeat Dosing. Advanced Healthcare Materials, 13(17). https://doi.org/10.1002/adhm.202304033

Vancouver

Sanchez AJDS, Loughrey D, Echeverri ES, Huayamares SG, Radmand A, Paunovska K, et al. Substituting Poly(ethylene glycol) Lipids with Poly(2‐ethyl‐2‐oxazoline) Lipids Improves Lipid Nanoparticle Repeat Dosing. Advanced Healthcare Materials. 2024;13(17). doi:10.1002/adhm.202304033

BibTeX
@article{Sanchez2024,
  author = {Sanchez, Alejandro J Da Silva and Loughrey, David and Echeverri, Elisa Schrader and Huayamares, Sebastian G and Radmand, Afsane and Paunovska, Kalina and Hatit, Marine and Tiegreen, Karen E and Santangelo, Philip J and Dahlman, James E},
  title = {Substituting Poly(ethylene glycol) Lipids with Poly(2‐ethyl‐2‐oxazoline) Lipids Improves Lipid Nanoparticle Repeat Dosing},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {17},
  doi = {10.1002/adhm.202304033}
}
Kostenlos starten →